Calcific uremic arteriolopathy in association with low turnover uremic bone disease
- PMID: 10499311
Calcific uremic arteriolopathy in association with low turnover uremic bone disease
Abstract
We report seven cases (out of 100 dialysis patients) at the University of Kentucky who were diagnosed with calciphylaxis syndrome between 1993 and 1998. Of note is the fact that five of these patients had bone biopsy-proven adynamic renal bone disease, rather low intact PTH, and relatively low calcium-phosphorus product. This is in contrast to the previous view that calciphylaxis is usually seen in patients with excessive parathyroid activity. The reemergence of calciphylaxis with renal bone disease is an intriguing finding and does not correspond to earlier reports associating calciphylaxis with hyperparathyroid bone disease. This report reviews the clinical, biochemical, and bone histology findings of these patients, and provides a review of the literature.
Similar articles
-
Calciphylaxis: risk factors, diagnosis, and treatment.Am J Kidney Dis. 2015 Jul;66(1):133-46. doi: 10.1053/j.ajkd.2015.01.034. Epub 2015 May 7. Am J Kidney Dis. 2015. PMID: 25960299 Free PMC article. Review.
-
Calciphylaxis: a rare complication of patients who required parathyroidectomy for advanced renal hyperparathyroidism.World J Surg. 2005 May;29(5):632-5. doi: 10.1007/s00268-005-7514-9. World J Surg. 2005. PMID: 15827857
-
Calcific uremic arteriolopathy: a call for action.Semin Nephrol. 2014 Nov;34(6):641-7. doi: 10.1016/j.semnephrol.2014.09.007. Semin Nephrol. 2014. PMID: 25498382 Review.
-
Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates.J Am Acad Dermatol. 2007 Dec;57(6):1021-5. doi: 10.1016/j.jaad.2007.06.029. J Am Acad Dermatol. 2007. PMID: 18021849
-
A Fatal Case of Non-Uremic Calciphylaxis: A Case Report and Literature Review.Am J Case Rep. 2018 Jul 9;19:804-807. doi: 10.12659/AJCR.909546. Am J Case Rep. 2018. PMID: 29983410 Free PMC article. Review.
Cited by
-
The Effect of Cinacalcet on Calcific Uremic Arteriolopathy Events in Patients Receiving Hemodialysis: The EVOLVE Trial.Clin J Am Soc Nephrol. 2015 May 7;10(5):800-7. doi: 10.2215/CJN.10221014. Epub 2015 Apr 17. Clin J Am Soc Nephrol. 2015. PMID: 25887067 Free PMC article. Clinical Trial.
-
Calciphylaxis.Postgrad Med J. 2001 Sep;77(911):557-61. doi: 10.1136/pmj.77.911.557. Postgrad Med J. 2001. PMID: 11524512 Free PMC article. Review.
-
Calcific uraemic arteriolopathy: a rare disease with a potentially high impact on chronic kidney disease-mineral and bone disorder.Pediatr Nephrol. 2014 Dec;29(12):2289-98. doi: 10.1007/s00467-013-2746-7. Epub 2014 Jan 29. Pediatr Nephrol. 2014. PMID: 24474577 Review.
-
A case report of severe calciphylaxis - suggested approach for diagnosis and treatment.BMC Nephrol. 2017 Apr 21;18(1):137. doi: 10.1186/s12882-017-0556-z. BMC Nephrol. 2017. PMID: 28431568 Free PMC article.
-
The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84).J Clin Endocrinol Metab. 2010 Jun;95(6):2772-80. doi: 10.1210/jc.2009-1909. Epub 2010 Apr 9. J Clin Endocrinol Metab. 2010. PMID: 20382692 Free PMC article.